ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2015

Are immune signatures a worthwhile tool for decision making in early-stage human epidermal growth factor receptor 2-positive breast cancer?

John A Foekens et al.PubMed ↗Publisher ↗

No numbers read from the abstract.